Marinomed seeks partner for potential influenza treatment
This article was originally published in Scrip
Executive Summary
Marinomed Biotechnologie, a young Austrian biotechnology company with a product on the market for the prevention and treatment of the common cold and viral-induced respiratory infections, is looking for a partner that will realise the full potential of the product.